Literature DB >> 33586093

The sepsis induced defective aggravation of immune cells: a translational science underling chemico-biological interactions from altered bioenergetics and/or cellular metabolism to organ dysfunction.

Waleed Hassan Almalki1.   

Abstract

Sepsis is described as a systemic immune response of the body to an infectious process that might result in dysfunctional organs that may lead to death. In clinical practice, sepsis is considered a medical emergency. The initial event in sepsis caused by a deregulated host response towards harmful microorganisms that leads to an aggravated systemic inflammatory response syndrome (SIRS) to tackle with pathogen invasion and a compensatory anti-inflammatory response syndrome (CARS) that lasts for several days. The inflammatory response and the cellular damage as well as the risk of an organ dysfunction are in direct proportion. Even though, the pathogenesis of sepsis remains unclear, many studies have shown evidence of role of oxidants and antioxidants in sepsis. The altered innate and adaptive immune cell and upregulated production and release of cytokines and chemokines most probably due to involvement of JAK-STAT pathway, disturbance in redox homeostasis due to low clearance of lactate and other oxidative stressors, contributes to sepsis process to organ dysfunction which contribute to increase rates of mortality among these patients. Hence, the treatment strategies for sepsis include antibiotics, ventilator and blood glucose management and other strategies for resuscitation are rapidly progressing. In the current review, we mainly concentrate on throwing light on the main molecular aspects and chemico-biological interactions that shows involvement in pathways manipulating alteration in physiology of immune cells (innate and adaptive) that change the bioenergetics/cellular metabolism to organ dysfunction and correlation of these altered pathway, improve the understating for new therapeutic target for sepsis.

Entities:  

Keywords:  Apoptosis; Cellular metabolism; JAK–STAT pathway; NF-κB; Pathogen-associated molecular patterns; TNF-alpha; Transforming growth factor-β-activated kinase-1

Mesh:

Substances:

Year:  2021        PMID: 33586093     DOI: 10.1007/s11010-021-04066-9

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  49 in total

Review 1.  The nuclear factor NF-kappaB pathway in inflammation.

Authors:  Toby Lawrence
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-07       Impact factor: 10.005

Review 2.  Severe sepsis and septic shock.

Authors:  Derek C Angus; Tom van der Poll
Journal:  N Engl J Med       Date:  2013-08-29       Impact factor: 91.245

3.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 4.  Sepsis and septic shock.

Authors:  Richard S Hotchkiss; Lyle L Moldawer; Steven M Opal; Konrad Reinhart; Isaiah R Turnbull; Jean-Louis Vincent
Journal:  Nat Rev Dis Primers       Date:  2016-06-30       Impact factor: 52.329

Review 5.  High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule.

Authors:  Huan Yang; Haichao Wang; Sangeeta S Chavan; Ulf Andersson
Journal:  Mol Med       Date:  2015-10-27       Impact factor: 6.354

Review 6.  Cell type-specific function of TAK1 in innate immune signaling.

Authors:  Adebusola A Ajibade; Helen Y Wang; Rong-Fu Wang
Journal:  Trends Immunol       Date:  2013-05-07       Impact factor: 16.687

Review 7.  Mechanisms and treatment of organ failure in sepsis.

Authors:  Christophe Lelubre; Jean-Louis Vincent
Journal:  Nat Rev Nephrol       Date:  2018-07       Impact factor: 28.314

Review 8.  Ubiquitin signaling in immune responses.

Authors:  Hongbo Hu; Shao-Cong Sun
Journal:  Cell Res       Date:  2016-03-25       Impact factor: 25.617

Review 9.  Precision Immunotherapy for Sepsis.

Authors:  Annemieke M Peters van Ton; Matthijs Kox; Wilson F Abdo; Peter Pickkers
Journal:  Front Immunol       Date:  2018-09-05       Impact factor: 7.561

10.  Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.

Authors:  Kristina E Rudd; Sarah Charlotte Johnson; Kareha M Agesa; Katya Anne Shackelford; Derrick Tsoi; Daniel Rhodes Kievlan; Danny V Colombara; Kevin S Ikuta; Niranjan Kissoon; Simon Finfer; Carolin Fleischmann-Struzek; Flavia R Machado; Konrad K Reinhart; Kathryn Rowan; Christopher W Seymour; R Scott Watson; T Eoin West; Fatima Marinho; Simon I Hay; Rafael Lozano; Alan D Lopez; Derek C Angus; Christopher J L Murray; Mohsen Naghavi
Journal:  Lancet       Date:  2020-01-18       Impact factor: 202.731

View more
  2 in total

1.  Ketamine inhibits TNF-α-induced cecal damage by enhancing RIP1 ubiquitination to attenuate lethal SIRS.

Authors:  Bin Deng; Daowei Yang; Huanghui Wu; Lu Wang; Rui Wu; Hongrui Zhu; Ailing Huang; Jingyi Song; Tieliang Cai; Shanshan Liu; Jingsi Wu; Huiying Zhou; Chunhui Li
Journal:  Cell Death Discov       Date:  2022-02-19

2.  Oxidant/Antioxidant Status Is Impaired in Sepsis and Is Related to Anti-Apoptotic, Inflammatory, and Innate Immunity Alterations.

Authors:  Marianna Miliaraki; Panagiotis Briassoulis; Stavroula Ilia; Kalliopi Michalakakou; Theodoros Karakonstantakis; Aikaterini Polonifi; Kalliopi Bastaki; Efrossini Briassouli; Konstantinos Vardas; Aikaterini Pistiki; Maria Theodorakopoulou; Theonymfi Tavladaki; Anna-Maria Spanaki; Eumorfia Kondili; Helen Dimitriou; Maria Venihaki; Sotirios Tsiodras; Dimitrios Georgopoulos; Marina Mantzourani; Serafeim Nanas; Apostolos Armaganidis; George L Daikos; Ioannis Papassotiriou; George Briassoulis
Journal:  Antioxidants (Basel)       Date:  2022-01-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.